Online Only Articles

Imatinib and ruxolitinib association: first experience in two patients

Oncohematology Unit of the Elderly, Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Milan, Italy;Hematopathology Service, Division of Pathology, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Milan, Italy;Division of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy;Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Hematopathology Service, Division of Pathology, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Milan, Italy
Division of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy
Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Oncohematology Division, IRCCS Ca’ Granda – Maggiore Policlinico Hospital Foundation, and University of Milan Medical School, Italy
Vol. 99 No. 6 (2014): June, 2014 https://doi.org/10.3324/haematol.2013.102525